Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,267 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Plasma Concentration and Pharmacodynamics of Edoxaban in Patients with Nonvalvular Atrial Fibrillation and Acute Heart Failure.
Nabeta T, Kida K, Ishida M, Shiono T, Suzuki N, Doi S, Tsukahara M, Ohta Y, Kimura T, Yamaguchi K, Takita A, Matsumoto N, Akashi YJ, Ako J, Inomata T. Nabeta T, et al. Among authors: matsumoto n. Clin Pharmacokinet. 2021 Aug;60(8):1061-1071. doi: 10.1007/s40262-021-00999-y. Epub 2021 Mar 30. Clin Pharmacokinet. 2021. PMID: 33782831 Free PMC article.
The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillation.
Shimokawa H, Yamashita T, Uchiyama S, Kitazono T, Shimizu W, Ikeda T, Kamouchi M, Kaikita K, Fukuda K, Origasa H, Sakuma I, Saku K, Okumura Y, Nakamura Y, Morimoto H, Matsumoto N, Tsuchida A, Ako J, Sugishita N, Shimizu S, Atarashi H, Inoue H. Shimokawa H, et al. Among authors: matsumoto n. Int J Cardiol. 2018 May 1;258:126-132. doi: 10.1016/j.ijcard.2018.01.141. Epub 2018 Feb 3. Int J Cardiol. 2018. PMID: 29429636 Free article. Clinical Trial.
Study Design and Baseline Characteristics of the EXPAND Study: Evaluation of Effectiveness and Safety of Xa Inhibitor, Rivaroxaban for the Prevention of Stroke and Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-Valvular Atrial Fibrillation.
Ikeda T, Atarashi H, Inoue H, Uchiyama S, Kitazono T, Yamashita T, Shimizu W, Kamouchi M, Kaikita K, Fukuda K, Origasa H, Sakuma I, Saku K, Okumura Y, Nakamura Y, Morimoto H, Matsumoto N, Tsuchida A, Ako J, Sugishita N, Shimizu S, Shimokawa H. Ikeda T, et al. Among authors: matsumoto n. Tohoku J Exp Med. 2016 Dec;240(4):259-268. doi: 10.1620/tjem.240.259. Tohoku J Exp Med. 2016. PMID: 27904005 Free article.
3,267 results